Shasun Pharmaceutical Division develops & manufactures formulations for solid dosage products. Shasun is a vertically integrated formulations partner for the pharmaceutical industry and is focused on Europe, North America, Japan and other regulated markets. Its services include formulation research & development activities, analytical method development and validation, scale-up & technology transfer, clinical supplies manufacturing to full scale commercial manufacturing of oral solid dosage forms.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CONCERTAI NAMES CLAUDIO D'AMBROSIO, PHD, AS HEAD OF BIOPHARMA PARTNERSHIPS AND RWE SOLUTIONS

Prnewswire | September 10, 2020

news image

ConcertAI has hired Claudio D'Ambrosio, PhD, as head of biopharma partnerships and real-world evidence Solutions. Claudio brings over 15 years of experience as a cancer researcher, commercial leader, and strategic scientific partner to the life sciences industry to help advance the goals of ConcertAI of bringing rapid innovation and precision real-world evidence oncology to the world's top global pharmaceutical companies. ConcertAI is a fast-growing company with the leading technology fo...

Read More

Pharma Tech

ILC DOVER ANNOUNCES NORTH AMERICA EXPANSION TO MEET GROWING DEMAND

ILC Dover | March 11, 2022

news image

ILC Dover LP specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business and entry into sterile liquid handling and chemicals content market. This investment will generate additional production capacity for its single-use powder storage, s...

Read More

Business Insights

PRIME MEDICINE EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS TO SUPPORT CONTINUED GROWTH AND ADVANCEMENT OF PRIME EDITING TECHNOLOGY AND PORTFOLIO

Prime Medicine | July 29, 2022

news image

Prime Medicine, Inc. a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying Prime Editing technology “Prime Medicine is advancing a first-of-its-kind technology intended to expand the number of patients who may benefit from genetic medicines. We are thrilled to welcome Richard, Niamh and Fubao to the team. Together, they bri...

Read More

Business Insights

AVIDIEN TECHNOLOGIES RECEIVES $4M INVESTMENT FROM BROADOAK CAPITAL PARTNERS

Avidien Technologies | February 02, 2022

news image

Avidien announced a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. "The partnership with BroadOak is exciting and ushers in the next phase for Avidien by creating the opportunity to quickly scale up the business with investments in new products, sales, marketing, and manufacturing." ...

Read More
news image

CONCERTAI NAMES CLAUDIO D'AMBROSIO, PHD, AS HEAD OF BIOPHARMA PARTNERSHIPS AND RWE SOLUTIONS

Prnewswire | September 10, 2020

ConcertAI has hired Claudio D'Ambrosio, PhD, as head of biopharma partnerships and real-world evidence Solutions. Claudio brings over 15 years of experience as a cancer researcher, commercial leader, and strategic scientific partner to the life sciences industry to help advance the goals of ConcertAI of bringing rapid innovation and precision real-world evidence oncology to the world's top global pharmaceutical companies. ConcertAI is a fast-growing company with the leading technology fo...

Read More
news image

Pharma Tech

ILC DOVER ANNOUNCES NORTH AMERICA EXPANSION TO MEET GROWING DEMAND

ILC Dover | March 11, 2022

ILC Dover LP specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business and entry into sterile liquid handling and chemicals content market. This investment will generate additional production capacity for its single-use powder storage, s...

Read More
news image

Business Insights

PRIME MEDICINE EXPANDS LEADERSHIP TEAM WITH KEY APPOINTMENTS TO SUPPORT CONTINUED GROWTH AND ADVANCEMENT OF PRIME EDITING TECHNOLOGY AND PORTFOLIO

Prime Medicine | July 29, 2022

Prime Medicine, Inc. a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying Prime Editing technology “Prime Medicine is advancing a first-of-its-kind technology intended to expand the number of patients who may benefit from genetic medicines. We are thrilled to welcome Richard, Niamh and Fubao to the team. Together, they bri...

Read More
news image

Business Insights

AVIDIEN TECHNOLOGIES RECEIVES $4M INVESTMENT FROM BROADOAK CAPITAL PARTNERS

Avidien Technologies | February 02, 2022

Avidien announced a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. "The partnership with BroadOak is exciting and ushers in the next phase for Avidien by creating the opportunity to quickly scale up the business with investments in new products, sales, marketing, and manufacturing." ...

Read More

Resources

resource image

Pharma Tech

ValGenesis e-Logbook

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us